Jeil Pharma Holdings Inc (KRX:002620)

South Korea · Delayed Price · Currency is KRW

7,200.00

-20.00 (-0.28%)

Oct 23, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Sector	663.20B	794.70B	818.40B	812.94B	778.72B
Connection Adjustment	-20.43B	-29.53B	-28.04B	-31.59B	-28.07B
Investment Division	14.84B	14.65B	13.69B	11.61B	11.92B
Total	657.61B	779.82B	804.04B	792.96B	762.57B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other Areas	19.43B	23.15B	-	-	-
South Korea	643.12B	765.50B	777.17B	786.91B	761.64B
Japan	15.50B	20.71B	-	-	-
Consolidated Adjustments	-20.43B	-29.53B	-28.04B	-31.59B	-30.07B
Overseas	-	-	54.92B	37.64B	31.00B